|
Market Cap (25-Jun) $80,439,416 (1,515th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 402,075 |
Shortsold (10-Feb) 29,568 (0.00%) (623rd) |
|
52w High $0.027 |
52w Low $0.003 |
P/E 4.78 |
EPS 0 |
AVE released this announcement to the ASX on 10 January 2022, 15:29. The announcement is not marked as price sensitive, and is 1 page(s) in length and 171.34kb in size.
You can view all announcements from AVE and see how they appear on a price chart on the announcements page.
At the date of this announcement, AVE was 0.001% short sold according to ASIC data. It was ranked the 623rd most shorted stock on the ASX. It remains ranked 623rd as of the latest reported data (10 February 2025).
| Other Recent Announcements from AVE | |
|---|---|
| Update - Application for quotation of securities - AVE | 28 June 2023, 11:48 |
| Application for quotation of securities - AVE | 28 June 2023, 11:43 |
| AVE CBD capsule passes two-year stability milestone | 22 June 2023, 8:57 |
| Section 708A Cleansing Statement | 10 January 2022, 15:29 |
| AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis | 20 December 2021, 10:43 |
| Positive results from Avecho's Phase I trial of CBD soft-gel | 8 December 2021, 8:59 |
| September 2021 Quarterly Activities Report & Appendix 4C | 29 October 2021, 8:49 |
You must be logged in to post a reply.
Avecho Biotechnology 